2025 Vision: Taiwan’s Pharmacy Market Skyrockets to USD 4.6 Bn: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit The Taiwan pharmaceutical market is projected to reach $4.6 Bn by 2025. Unlike neighbouring countries like Japan and China, the presence of pharmacy chains in Taiwan is comparatively lower. STORY OUTLINE The pharmacy market in Taiwan has grown by ~2.5% in recent years, with an increasing emphasis on the utilization of Western medicine. In 2019, Taiwan had 8,129 pharmacy retailers, adopting various models to enhance convenience and expand product offerings. Competition in Taiwan’s pharmaceutical sector is intense, with organized chains contributing around 35% of revenue. According to Ken Research, the top three pharmacy chains in terms of revenue are Great Tree Pharmacy, Med first, and TinTin Drugstore, collectively holding a market share of around 13%. The pharmacy market in Taiwan has witnessed significant growth of ~2.5 % in recent years. The utilization of Western medicine is on the rise in Taiwan, with a growing emphasis on its usage. This is reflected in the expenditure on pharmaceutical products as a percentage of the GDP, which witnessed a slight increase from ~1.10% in 2014 to ~1.15% in 2018. Taiwan’s pharmacy market continues to evolve, meeting the diverse healthcare needs of its population. Taiwan’s pharmaceutical industry encompasses four distinct sub-sectors: Active Pharmaceutical Ingredients (APIs), Western medicine, Traditional Chinese Medicine (TCM), and biologics. Taiwanese biopharmaceutical companies have formed alliances with contract research organizations and multinational pharmaceutical companies in order to enhance clinical investments within Taiwan. In 2019, Taiwan was home to a remarkable count of 8,129 pharmacy retailers, each operating within the country’s borders. These pharmacies are actively embracing various models to enhance customer convenience, while also expanding their product offerings to cater to a wider range of consumer needs. Explore Technological Integration Taiwan’s population trends are changing as the fertility rate is shrinking (1.06 births per women as of 2018) and life expectancy is increasing. The population growth in 2019 was ~0.1% down from an average of ~1.5% during the 1980s. This has resulted with the population starting to decline as of 2020. Out of total population, 65 years and older people accounted for ~15% of the population in 2019. It is estimated this will exceed to more than 20% till 2025. As per the NHIA data the cost on healthcare increases with the increase in age. Thus, it will benefit the market in the future. As the elderly population continues to grow, there will be an increasing demand for healthcare services and products in Taiwan. This trend presents opportunities for market growth and development in the healthcare sector, providing potential benefits for various stakeholders. Intense Competition in Taiwan’s Pharmaceutical Sector, in 2019, ~35% of the total revenue in the pharmaceutical sector came from Organized Chains, while the remaining ~65% was contributed by Unorganized Pharmacies. To learn more about this report Download a Free Sample Report Among the pharmacy chains, Great Tree Pharmacy, Med first, and TinTin Drugstore emerged as the top three in terms of revenue, collectively holding a market share of around 13%. On the other hand, based on the number of stores, Med first, Great Tree, and Your Chance took the lead, accounting for ~6% of the market share. In conclusion, Taiwan’s pharmacy market has experienced significant growth, driven by the rising utilization of Western medicine and evolving healthcare needs. The industry encompasses diverse sub-sectors and has witnessed alliances with global players to boost investments. With a changing population demographic and intense competition, opportunities arise for healthcare services and products, paving the way for market development and stakeholder benefits. Post Views: 5 Tags: Apothecary Industry Taiwan, Apothecary Market Challenges Taiwan, Competitors in Pharmacy Industry Taiwan, E-Pharmacy Market Taiwan, Emerging Players in E Pharmacy Sector, Funds Raised Start-Ups E- Pharmacy Services Taiwan, GSK Market Size Taiwan, Healthcare Sector Taiwan, Investors In Pharmacy Market Taiwan, Leading Players in Pharmacy Sector Taiwan, Licensed Pharmacy Taiwan, Lilly Market Size Taiwan, Major Players in Sector Taiwan, Medicinal Store Customer Taiwan, Novartis Market Revenue Taiwan, Online Pharmacy Subscriber Taiwan, Opportunities Pharmaceutical Industry Taiwan, Pharmaceutical Sector Taiwan, Pharmacy Industry Financial Position Taiwan, Pharmacy Technological Update Taiwan, Registered Health Center Taiwan, Sanofi Pharma Market Size Taiwan, Taiwan Chemist Market, Taiwan Healthcare Expenditure, Taiwan NHI-Covered Medications, Taiwan Pharmaceutical Expenditure, Taiwan Pharmaceutical Market Innovations, Taiwan Pharmacy Market, Taiwan Unorganized Pharmacies, Top 5 Funded Pharmacy Companies Taiwan, Top Captive Players Taiwan E-Pharmacy Industry, Your Chance Market Revenue Taiwan, Zuellig Market Share Taiwan